These data suggest that RKIP functions as proliferation inhibitor and anti-apoptotic factor in the irradiated NPC cells, which is consistent with RKIP-inhibiting ERK and AKT activity. The gene discussed is MAPK1; the disease is nasopharyngeal carcinoma.